Skip to main content Skip to navigation

Summary of 2018-2019 Meetings

Below is the list of meetings planned in the current academic year.




Led by


23 October 2018

A 130

Discussion of Draft Guidance released by the FDA for 1) Master Protocols, and 2) Adaptive Designs

Deepak Parashar & Nigel Stallard

  1. Master Protocols: Efficient Clinical Trial Design Strategies to Expedite Development of Oncology Drugs and Biologics
  2. Adaptive Designs for Clinical Trials of Drugs and Biologics

13 November 2018

A 042

Clinical measurement: the neglected tool in the research design armamentarium

Timothy Hofer


24 January 2019

A 150

Global burden of cancers attributable to infections

Martyn Plummer

  1. Plummer et al (2016)
  2. de Martel et al (2017)
  3. Maucort-Boulch et al (2018)

25 February 2019

A 039

Meaningful data at scale: opportunities for delivering better treatments to the right patients faster and more safely

Chris Harbron


07 May 2019

A 042

Discussion of new FDA regulatory guidance for 1) Enrichment Strategies, and 2) Rare Diseases

Roundtable Discussion

1. Enrichment Strategies for Clinical Trials to Support Determination of Effectiveness of Human Drugs and Biological Products

2. Rare Diseases: Natural History Studies for Drug Development

14 June 2019


A global perspective on measuring early child development in non-Western settings

Gillian Lancaster


24 June 2019


Joint S+E Unit / WCTU Workshop:

  1. Multiplicity in confirmatory clinical trials with master protocols
  2. Adjusting for subpopulation selection in two-stage designs with time to event data
  3. A brief comparison of alternative falls data collection methods in the Prevention of Falls Injury Trials
  4. TBC

Nigel Stallard

Peter Kimani

James Griffin

Chen Ji


All meetings take place 11am - 12noon unless stated otherwise.

N.B. Please click the doi link to access articles with your Warwick login.